glp 1 agonists uses GLP-1 GLP-1 receptor agonists and beyond.
Description
Suspected side effects should be reported via the Yellow Card website (yellowcard.mhra.gov.uk) or the Yellow Card app
If tirzepatide is producing the desired outcomes, there is no compelling reason to switch to a less proven compound with more side effects
Dungan KM, Povedano ST, Forst T, Gonzlez JG, Atisso C, Sealls W, et al
Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, et al
The remaining trials (TRIUMPH-2/-3/-4 and TRIUMPH-Outcomes) are still anticipated through 20262028
